~~<i id='CB13EFCC7C'><strike id='CB13EFCC7C'><tt id='CB13EFCC7C'><pre id='CB13EFCC7C'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：comprehensive 2025-09-28 01:11:23 Page View：8151

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： CDC backtracks, saying fully vaccinated people can go maskless indoors
Next article： Moonlake's readout produced a cash windfall. Risks remain

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Court strikes down limits on filming of police in Arizona

FILE-PhoenixPolicestandinfrontofpoliceheadquartersonMay30,2020,inPhoenix,waitingforprotestersmarchin

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

HIPAA doesn't protect reproductive records from prosecutors

HyacinthEmpinado/STATWithRoev.Wadenowoverturned,patientsarewonderingwhetherfederallawswillshieldthei